Position in MRK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$9,220,516
-$972,975 QoQ
Shares Held
71,755
-15.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#777
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEEDER ASSET MANAGEMENT INC holds $140,500,918 across 9 Drug Manufacturers - General names. MRK ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,922 | $34,689,912 | |
| 2 | JNJ |
Johnson & Johnson
|
117,192 | $29,763,248 | |
| 3 | ABBV |
AbbVie Inc.
|
98,512 | $24,789,557 | |
| 4 | AMGN |
Amgen Inc
|
65,451 | $23,701,113 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
135,547 | $17,125,003 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
71,755 | $9,220,516 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
20,426 | $1,176,942 | |
| 8 | PFE |
Pfizer Inc
|
1,115 | $26,849 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,220,516 | 71,755 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $10,193,491 | 84,741 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $7,927,549 | 75,314 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $628,215 | 7,485 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $592,274 | 7,482 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $662,966 | 7,386 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $755,649 | 7,596 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $7,073,195 | 62,286 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $31,048,421 | 250,795 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,397,878 | 10,594 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $764,339 | 7,011 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $835,027 | 8,111 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,685,143 | 83,934 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $9,447,321 | 88,799 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,671,062 | 87,166 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,570,907 | 134,358 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,131,077 | 133,060 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $10,510,520 | 128,099 | Shares | Defined | 2022-05-10 | |
| 2021-09-30 | $13,936,956 | 185,554 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $14,520,592 | 186,712 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $14,246,777 | 184,807 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $1,482,215 | 18,120 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $14,437,699 | 174,053 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $13,464,005 | 174,111 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $12,392,254 | 161,064 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||